Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afra Pharma is a pharmaceutical company headquartered in Tehran, Iran, specializing in the development, manufacturing, and marketing of generic medicines and dietary supplements. Since its inception in 2011, the company has built a comprehensive portfolio addressing therapeutic areas such as metabolic diseases, neurology, and cardiovascular health. Afra Pharma's manufacturing operations are conducted in facilities that adhere to Good Manufacturing Practice (GMP) standards, ensuring the quality and safety of its products. The company's offerings include widely used medications like metformin and gabapentin, as well as specialized supplements like Vitamin D3 and melatonin. Afra Pharma serves the domestic Iranian market and has expanded its reach through international distribution channels, particularly in the Middle East and UAE.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Afra-Pharma.